ITGAV and breast cancer: In addition, high expression of ITGAV significantly influenced the level of immune cell infiltration in lung adenocarcinoma and Triple-Negative breast cancer and was associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC) and osteosarcoma (16–19).